Abstract
Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are B-cell lymphoproliferative disorders characterized by a proliferation of mature-appearing but functionally incompetent lymphocytes. The result of this proliferation is an accumulation of lymphocytes that progressively infiltrate the lymph nodes, bone marrow, liver, and spleen. CLL and SLL are classified by the World Health Organization as the same disease entity [1]. They are identical histologically and immunophenotypically, but their manifestation is different: CLL manifests primarily in peripheral blood or bone marrow and SLL in the lymph nodes.
Keywords
- Chronic Lymphocytic Leukemia
- Complete Remission Rate
- Chronic Lymphocytic Leukemia Cell
- Secondary Cancer
- Small Lymphocytic Lymphoma
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
Lin TS, Awan FT, Byrd JC. Clinical manifestations, staging, and treatment of indolent non-Hodgkin’s lymphoma. In: Hoffman R, Benz EJ, Shattil SJ, et al., editors. Hematology: basic principles and practice. 5th ed. Philadelphia: Elsevier; 2009. p. 1327–47.
Amato D, Oscier DG, Davis Z, et al. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis. Am J Clin Pathol. 2007;128(2):333–8.
Tsimberidou AM, Wen S, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol. 2009;27(6):904–10.
NCCN Clinical Practice Guidelines in Oncology: Non-Hodgkin’s Lymphoma v4.2011. National Comprehensive Cancer Network. Accessed 23 May 2012.
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975;46(2):219–34.
Binet JL, Aquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981;48:198–206.
Campo E, Swerdlow SH, Harris N, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019–32.
Tsimberidou AM, Wen S, O’Brien S, et al. Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at The University of Texas MD Anderson Cancer Center. J Clin Oncol. 2007;25(29):4648–56.
Keating MJ, Kantarjian H, Talpaz M, et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia. Blood. 1989;74:19–25.
Keating MJ, O’Brien S, Albitar M, et al. Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia. J Clin Oncol. 2005;23:4079–88.
Khouri IF, Keating M, Korbling M, et al. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol. 1998;16(8):2817–24.
Tsimberidou AM, Keating MJ. Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options. Leuk Lymphoma. 2010;51(7):1188–99.
Brown JR. The treatment of relapsed refractory chronic lymphocytic leukemia. Hematology Am Soc Hematol Educ Program. 2011;2011:111–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Tsimberidou, AM., Keating, M.J. (2013). Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. In: Rodriguez, M., Walters, R., Burke, T. (eds) 60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5197-6_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5197-6_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5196-9
Online ISBN: 978-1-4614-5197-6
eBook Packages: MedicineMedicine (R0)